Vaccine development remains central to reducing incident HIV globally, particularly where long-acting PrEP access is limited, with therapeutic and preventive approaches advancing in parallel.

Few viruses have instilled as much fear as HIV. Although it was discovered nearly 40 years ago, we still do not have a vaccine or a cure. But the COVID-19 pandemic has rivaled that level of fear as ...

Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to a manageable lifetime condition for those who are successfully being treated.Initially, ...

Within half a century, the world has experienced two elusive and deadly viral diseases responsible for pandemics. While there are many similarities between the ongoing HIV pandemic and the current ...

In a recent study posted to Research Square* preprint server, researchers assessed the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-CoV envelope (E) proteins on ...